Abstract
Background Liquefied petroleum gas (LPG) stoves have been promoted in low- and middle-income countries (LMICs) as a clean energy alternative to biomass burning cookstoves.
Objective We sought to characterize kitchen area concentrations and personal exposures to nitrogen dioxide (NO2) within a randomized controlled trial in the Peruvian Andes. The intervention included the provision of an LPG stove and continuous fuel distribution with behavioral messaging to maximize compliance.
Methods We measured 48-hour kitchen area NO2 concentrations at high temporal resolution in homes of 50 intervention participants and 50 control participants longitudinally within a biomass-to-LPG intervention trial. We also collected 48-hour mean personal exposures to NO2 among a subsample of 16 intervention and 9 control participants. We monitored LPG and biomass stove use continuously throughout the trial.
Results In 367 post-intervention 24-hour kitchen area samples of 96 participants’ homes, geometric mean (GM) highest hourly NO2 concentration was 138 ppb (geometric standard deviation [GSD] 2.1) in the LPG intervention group and 450 ppb (GSD 3.1) in the biomass control group. Post-intervention 24-hour mean NO2 concentrations were a GM of 43 ppb (GSD 1.7) in the intervention group and 77 ppb (GSD 2.0) in the control group. Kitchen area NO2 concentrations exceeded the WHO indoor hourly guideline an average of 1.3 hours per day among LPG intervention participants. GM 48-hour personal exposure to NO2 was 5 ppb (GSD 2.4) among 35 48-hour samples of 16 participants in the intervention group and 16 ppb (GSD 2.3) among 21 samples of 9 participants in the control group.
Discussion In a biomass-to-LPG intervention trial in Peru, kitchen area NO2 concentrations were substantially lower within the LPG intervention group compared to the biomass-using control group. However, within the LPG intervention group, 69% of 24-hour kitchen area samples exceeded WHO indoor annual guidelines and 47% of samples exceeded WHO indoor hourly guidelines. Forty-eight-hour NO2 personal exposure was below WHO indoor annual guidelines for most participants in the LPG intervention group, and we did not measure personal exposure at high temporal resolution to assess exposure to cooking-related indoor concentration spikes. Further research is warranted to understand the potential health risks of LPG-related NO2 emissions and inform current campaigns which promote LPG as a clean-cooking option.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT02994680
Clinical Protocols
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5670728/
Funding Statement
Financial support for the CHAP trial was received from the Global Environmental and Occupational Health, Fogarty International Center, United States National Institutes of Health (U01TW010107 and U2RTW010114); the Clean Cooking Alliance of the United Nations Foundation (UNF 16-810), the Johns Hopkins Center for Global Health, and the COPD Discovery Fund of Johns Hopkins University. The Center for Global Non-Communicable Disease Research and Training field site in Puno, Peru, also received generous support from Mr. William and Bonnie Clarke III. JLK and KNW were supported by the NIH Fogarty International Center, NINDS, NIMH, NHBLI and NIEHS under NIH Research Training Grant # D43 TW009340 and the Johns Hopkins Center for Global Health. JLK was also supported by the Ruth L. Kirschstein Institutional National Research Service Award (5T32ES007141-33) funded by the NIH/NIEHS. KNW was also supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number T32HL007534. MFDR was further supported by the Global Environmental and Occupational Health (GEOHealth), Fogarty International Center, and by the David Leslie Swift Fund of the Bloomberg School of Public Health, Johns Hopkins University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Johns Hopkins School of Public Health Institutional Review Board (00007128) A.B. PRISMA Ethical Institutional Committee (CE2402.16) Universidad Peruana Cayetano Heredia Institutional Review Board (66780)
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵+ Joint first authors
↵* Joint last authors
↵§ Cardiopulmonary outcomes and Household Air Pollution (CHAP) trial Investigators: Steering Committee: William Checkley MD PhD (Johns Hopkins University, Baltimore, MD, USA), Gustavo F Gonzales MD (Universidad Peruana Cayetano Heredia, Lima, Peru), Luke Naeher PhD (University of Georgia, Athens, GA, USA), Joshua Rosenthal PhD (National Institutes of Health, Bethesda, MD, USA), N Kyle Steenland PhD (Emory University, Atlanta, Georgia, USA).
Johns Hopkins University Investigators: Theresa Aguilar, Vanessa Burrowes PhD, Magdalena Fandiño-Del-Rio PhD, Elizabeth C Fung MSPH, Dina Goodman MSPH, Steven A Harvey PhD, Phabiola Herrera MD, Josiah L Kephart PhD, Kirsten Koehler PhD, Alexander Lee, Kathryn A Lee MPH, Catherine H Miele MD MPH, Mitra Moazzami MSPH, Lawrence H. Moulton PhD, Saachi Nangia, Carolyn O’Brien MSPH, Suzanne Simkovich MD MS, Timothy Shade, Lena Stashko MSPH, Ariadne Villegas- Gomez MSPH, Kendra N Williams PhD, Abigail Winiker MSPH.
Asociación Benéfica PRISMA Investigators: Marilu Chiang MD MPH, Gary Malpartida, Carla Tarazona-Meza MPH.
Washington University Investigators: Victor Davila-Roman MD, Lisa de las Fuentes MD.
Emory University Investigators: Dana Barr Boyd PhD, Maria Jolly MSPH, Angela Rozo MS.
Data Availability
Available upon reasonable request.